CrushSCI.com
Journal Selection & Manuscript Polishing Services
AMERICAN HEART JOURNAL journal cover Medicine
Back to journal directory

Review Cycle Records

AMERICAN HEART JOURNAL

Elsevier SCIE Non-OA
2026 Emerging Zone 22025 CAS Zone 22025 JCR Q2
178.9Average days
116Median days
42Fastest days
743Longest days
2882025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

168 days

Cardiac allograft vasculopathy and secondary outcomes at 1-year in heart transplantation from circulatory death donors

AuthorsShivank Madan; Lorenzo D’Angelo; Brandon Ferrell; Stephen J. Forest; Daniel B. Sims; Omar Saeed; Daniel J. Goldstein; Ulrich P. Jorde

AffiliationsDivision of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY

Source PDF DOI Publisher page
743 days

Dental procedures and associated risk of infective endocarditis

AuthorsEmil Fosbøl; Eva Havers-Borgersen; Anders Dahl; Jarl E. Strange; Claus Moser; Marianne Voldstedlund; Nikolaj Ihlemann; Louise Bruun Oestergaard; Lauge Østergaard; Andrew Wang; Vivian H. Chu; Morten Dahl; Søren Fanoe; Morten Schou; Trine Lauridsen; Nana Valeur; Gunnar H. Gislason; Niels Eske Bruun; Henning Bundgaard; Kasper Iversen; Lars Køber

AffiliationsThe Heart Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Denmark; Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Denmark; Department of Clinical Microbiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Immunology and Microbiology, University of Copenhagen, Denmark; Department of Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark; Department of Cardiology, University Hospital Bispebjerg, Copenhagen, Denmark; Department of Cardiology, Duke University, Durham, NC; Division of Infectious Diseases, Duke University, Durham, NC; Department of Oral and Maxillofacial Surgery, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; The Danish Heart Foundation, Copenhagen, Denmark; Department of Cardiology, Zealand University Hospital Roskilde, Denmark

Source PDF DOI Publisher page
130 days

Pregnancy outcomes in women with a history of myocarditis

AuthorsJasmin M. Nari; Sarah Siu; Rohan D’Souza; Birgit Pfaller; Danielle Massarella; Beatriz Fernandez-Campos; Candice K. Silversides

AffiliationsDepartment of Medicine, Division of Cardiology, University of Toronto Pregnancy and Heart Disease Program, Mount Sinai and Toronto General Hospitals, Toronto, Canada; Departments of Obstetrics and Gynecology and Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada; Department of Internal Medicine 1, University Hospital St. Pölten – NOE LGA, Karl Landsteiner University, St. Pölten, Austria

Source PDF DOI Publisher page
102 days

Efficacy and safety of revascularization in patients with chronic limb-threatening ischemia by kidney function

AuthorsJun Young Lee; Gomathy Parvathinathan; Sai Liu; Ali Etemadi; Margaret R. Stedman; Shipra Arya; Tara I. Chang

AffiliationsDepartment of Nephrology, Comprehensive Kidney Disease Research Institute, Yonsei University Wonju College of Medicine, Wonju, South Korea; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, CA; Division of Vascular Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA

Source PDF DOI Publisher page
175 days

Reconsidering fibrinolysis in selected patients with non–ST-elevation acute coronary syndrome: A hypothesis-generating, research-based framework

AuthorsCesar Rodrigo Zoni; Debabrata Mukherjee; Martha Gulati

AffiliationsTeaching and Research Department at Instituto de Cardiologia de Corrientes “Juana F. Cabral”, Corrientes, Argentina; Texas Tech University Health Sciences Center at El Paso, El Paso, TX; Department of Cardiology, The Davis Women’s Heart Center, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX

Source PDF DOI Publisher page
203 days

Rationale, design, and experiences from the vanguard phase of the bariatric surgery for the reduction of cardiovascular events (BRAVE) trial

AuthorsJorge A. Wong; David Conen; Aristithes Doumouras; Emma Van Reekum; Shrikant I. Bangdiwala; Kumar Balasubramanian; Shaheena Bashir; Sumathy Rangarajan; Marie-Eve Piché; Myriam Pettigrew; Dawn Agapay; Aldo P. Maggioni; Stefan Störk; Denis Pajecki; Ryan A. Davey; Remi Kouz; Roselyne Villiard; Satya Dash; Alvaro Avezum; Ricardo Cohen; Olga Castaner; Paul Poirier; Mehran Anvari; Salim Yusuf

AffiliationsPopulation Health Research Institute, Hamilton, Ontario, Canada; Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; Department of Surgery, St. Joseph’s Healthcare, Hamilton, Ontario, Canada; Department of Medicine, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, Quebec, Canada; ANMCO Research Center, Heart Care Foundation, Florence, Italy; Department Clinical Research & Epidemiology, Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany; Centro de Pesquisa Clinica, Hospital Nove de Julho, São Paulo, Brazil; Division of Cardiology, Western University, London, Ontario, Canada; Department of Medicine, Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Montréal, Quebec, Canada; Centre Hospitalier Régional de Lanaudière, Université Laval, Saint-Charles-Borromée, Quebec, Canada; Department of Medicine, Toronto General Hospital Research Institute, University of Toronto, Toronto, Ontario, Canada; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil; Centre for Obesity and Diabetes, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil; Department of Medicine, Cardiovascular Risk and Nutrition Research Group, Hospital del Mar Research Institute, Barcelona, Spain

Source PDF DOI Publisher page
42 days

Intensive blood-pressure control for the prevention of major cardiovascular events in patients with type 2 diabetes: Rationale, design and baseline characteristics of the OPTIMAL-DIABETES randomized trial

AuthorsKarla Santo; Eduardo Martins; Gisele S. Silva; Patricia O. Guimarães; Caio A.M. Tavares; João Brainer; Frederico Monfardini; Josué Nieri; Silvia R.L. Assis; João S. Felício; Fábio S. Silveira; Audes D.M. Feitosa; Miguel N. Hissa; Dario C. Sobral-Filho; José F. Vilela-Martin; Elizabeth E.S. Cestario; Juan C. Yugar-Toledo; Marcelo C. Batista; Luiz Turatti; Andrea A. Brandão; Weimar S. Barroso; Andrei C. Sposito; Luciano F. Drager; Luiz A. Bortolotto; Sandra C. Fuchs; Marcelo Franken; Pedro A. Lemos; Raul D. Santos; Anthony Rodgers; Paul K. Whelton; Flavio D. Fuchs; Otavio Berwanger

AffiliationsHospital Israelita Albert Einstein, São Paulo, Brazil; Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Faculdade de Medicina, Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Universidade de São Paulo, São Paulo, Brazil; João de Barros Barreto University Hospital, Federal University of Pará, Belém, Brazil; Centro de Pesquisa Clínica do Coração, Aracaju, Brazil; Pronto Socorro Cardiológico de Pernambuco (PROCAPE), University of Pernambuco, Recife, Brazil; Centro de Pesquisas em Diabetes e Doenças Endócrino-Metabólicas/Clínica Popular Endocrinologia, Fortaleza, Brazil; State Medicine School of São José do Rio Preto (FAMERP), São José do Rio Preto, Brazil; University Center of Votuporanga (UNIFEV), Votuporanga, Brazil; Faculty of Medical Sciences, Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil; Hypertension Unit, Medicine School, Federal University of Goiás, Goiânia, Brazil; Faculty of Medical Sciences, Clinical Research Center, State University of Campinas, Campinas, Brazil; Unidade de Hipertensão, Disciplina de Nefrologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil; Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; Faculty of Health Sciences, Universidad Autónoma de Chile, Providencia, Chile; George Institute for Global Health, Sydney, Australia; Tulane University Celia Scott Weatherhead School of Public Health and Tropical Medicine, New Orleans, LA; George Institute for Global Health UK, London, United Kingdom; Imperial College London, London, United Kingdom

Source PDF DOI Publisher page
71 days

Interpreting apparent differences among the major colchicine trials for cardiovascular prevention: A descriptive compatibility analysis

AuthorsThomas C. Scheier; Hertzel C. Gerstein; Arend Mosterd; Qilong Yi; John Eikelboom

AffiliationsPopulation Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Department of Cardiology, Meander Medical Center, Amersfoort, The Netherlands; Dutch Network for Cardiovascular Research (WCN), Utrecht, The Netherlands; Department of Epidemiology and Community Medicine, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada

Source PDF DOI Publisher page
88 days

Comparative effectiveness of torsemide vs furosemide in the management of heart failure patients: Win-ratio reanalysis of the TRANSFORM-HF trial

AuthorsGuangyu Tong; Yukang Zeng; Stephen J. Greene; Kevin J. Anstrom; Jeffrey Testani; Robert J. Mentz; Fan Li; Eric J. Velazquez

AffiliationsSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Cardiovascular Medicine Analytics Center, Yale School of Medicine, New Haven, CT; Department of Biostatistics, Yale School of Public Health, New Haven, CT; Department of Medicine, Division of Cardiology, Duke University School of Medicine, Durham, NC; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC

Source PDF DOI Publisher page
67 days

International study of coronary microvascular angina (iCorMicA): A registry-based diagnostic study and nested randomized trial

AuthorsDaniel Ang; Robin Young; Diann Taggart; David Carrick; Sudipta Chattopadhyay; Yogesh Raja; Kanarath Balachandran; Ahmed Elghamaz; John Greenwood; Stephen Hoole; James Cotton; Anirban Choudhury; Peter O’Kane; Sachin Jadhav; Ian Purcell; Rito Mitra; Ahmed Sabra; Joel Giblett; Robert Byrne; Kevin O'Gallagher; Eduardas Subkovas; Rajiv Rampat; Brijesh Anantharam; Ashwin Radhakrishnan; Colum Owens; Peter Damman; Bartłomiej Guzik; Damien Collison; Fiona Howarth; Liz Lennon; Patricia-Marielle Tolentino; Andrea Vicere; Kirsty Martin; Anna Kamdar; Robert Sykes; Rebecca Hanna; Dylan Tan; Robert Heggie; Olivia Wu; Paul Welsh; Thomas Ford; Chim Choy Lang; Vijay Kunadian; Alex McConnachie; Colin Berry

AffiliationsSchool of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom; West of Scotland Heart and Lung Center, Golden Jubilee National Hospital, Glasgow, United Kingdom; Robertson Center for Biostatistics, and Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom; Project Management Unit, Gartnavel Royal Hospital, NHS Greater Glasgow and Clyde Health Board, Glasgow, United Kingdom; Department of Cardiology, University Hospital Hairmyres, Glasgow, United Kingdom; Department of Cardiology, Bedford Hospital, Bedfordshire Hospital NHS Foundation Trust, Bedford, United Kingdom; Department of Cardiology, Sunderland Royal Hospital, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, United Kingdom; Department of Cardiology, Royal Blackburn Teaching Hospital, Blackburn, United Kingdom; Department of Cardiology, Northwick Park Hospital, London Borough of Brent, London North West University Healthcare NHS Trust, London, United Kingdom; Department of Cardiology, Leeds Teaching Hospitals NHS Trust, UK and the Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Cardiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom; Heart and Lung Centre, New Cross Hospital, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, United Kingdom; Department of Cardiology, Morriston Hospital, Swansea Bay University Health Board, Swansea, United Kingdom; Department of Cardiology, Royal Bournemouth Hospital, University Hospitals Dorset NHS Foundation Trust, Bournemouth, United Kingdom; Department of Cardiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; Department of Cardiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom; Department of Cardiology, University Hospital of Wales, Cardiff, United Kingdom; Department of Cardiology, Pinderfields Hospital, Mid Yorkshire Teaching Hospitals NHS Trust, Wakefield, United Kingdom; Department of Cardiology, Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, United Kingdom; Department of Cardiology, Mater Private Hospital and Cardiovascular Research Institute, Mater Private Network, Dublin, Ireland; Department of Cardiology, School of in the Faculty of Life Sciences and Medicine, King’s College Hospital, King’s College, London, United Kingdom; Department of Cardiology, Glan Clwyd Hospital Glan Clwyd Hospital, Betsi Cadwaladr University NHS Health Board, Rhyl, United Kingdom; Department of Cardiology, William Harvey Hospital, East Kent Hospitals University NHS Foundation Trust, Ashford, United Kingdom; Department of Cardiology, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom; Department of Cardiology, University Hospitals Coventry and Warwickshire NHS Trust, Warwickshire, United Kingdom; Department of Cardiology, Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, United Kingdom; Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands; Fifth Military Polyclinical Hospital, Jagiellonian University Medical College, Kraków, Poland; Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy; Health Economics and Health Technology Assessment (HEHTA), School of Health and Wellbeing, University of Glasgow, United Kingdom; School of Medicine and Public Health, The University of Newcastle, Callaghan, Australia; Cardiovascular Research, University of Dundee, UK and Tuanku Muhriz Royal Chair, National University of Malaysia, Kuala Lumpur, Malaysia; Cardiothoracic Centre, Freeman Hospital, Newcastle Hospitals and Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.